Skip Navigation
  Print Page

What treatments can reduce the chances of preterm labor & birth?

Skip sharing on social media links
Share this:

If a pregnant woman is showing signs of preterm labor, her doctor will often try treatments to stop labor and prolong the pregnancy until the fetus is more fully developed. Treatments include therapies to try to stop labor (tocolytics) and medications administered before birth to improve outcomes for the infant if born preterm (antenatal steroids to improve the respiratory outcomes and neuroprotective medications such as magnesium sulfate).

Medications to Delay Labor

Drugs called tocolytics (pronounced toh-coh-LIT-iks) can be given to many women with symptoms of preterm labor. These drugs can slow or stop contractions of the uterus and may prevent labor for 2 to 7 days. One common treatment for delaying labor is magnesium sulfate (pronounced mag-NEEZ-ee-um SUL-fate), given to the pregnant woman intravenously through a needle inserted in an arm vein.

Medications to Speed Development of the Fetus

Tocolytics may provide the extra time for treatment with corticosteroids (pronounced kohr-tuh-koh-STER-oids) to speed up development of the fetus's lungs and some other organs or for the pregnant woman to get to a hospital that offers specialized care for preterm infants. Corticosteroids can be particularly effective if the pregnancy is between 24 and 34 weeks (between 5½ and 7¾ months) and the woman's health care provider suspects that the birth may occur within the next week.1 Intravenously delivered magnesium sulfate may also reduce the risk of cerebral palsy if the child is born early.2


  1. American Congress of Obstetricians and Gynecologists. (2011). Early preterm birth FAQ. Retrieved April 23, 2012, from http://www.acog.org/~/media/For Patients/faq173.pdf?dmc=1&ts=20120323T1605318647 External Web Site Policy (PDF - 282 KB) [top]
  2. Rouse, D. J., Hirtz, D. G., Thom, E., Varner, M. W., Spong, C. Y., Mercer, B. M., et al. (2008). A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. New England Journal of Medicine, 359, 895–905. [top]

Last Updated Date: 11/30/2012
Last Reviewed Date: 11/06/2013
Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology